International Biotechnology Trust PLC Erasca, Inc. Transaction History
International Biotechnology Trust PLC
- $295 Million
- Q3 2023
A detailed history of International Biotechnology Trust PLC transactions in Erasca, Inc. stock. As of the latest transaction made, International Biotechnology Trust PLC holds 1,926,000 shares of ERAS stock, worth $4.55 Million. This represents 1.29% of its overall portfolio holdings.
Number of Shares
1,926,000
Previous 1,426,000
35.06%
Holding current value
$4.55 Million
Previous $3.94 Million
3.58%
% of portfolio
1.29%
Previous 1.23%
Shares
2 transactions
Others Institutions Holding ERAS
# of Institutions
117Shares Held
74.3MCall Options Held
7.1KPut Options Held
40.1K-
Arch Venture Management, LLC Chicago, IL11.1MShares$26.1 Million33.14% of portfolio
-
Black Rock Inc. New York, NY6.98MShares$16.5 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY6.17MShares$14.6 Million0.17% of portfolio
-
Artal Group S.A. Luxembourg, N44.72MShares$11.1 Million0.52% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.34MShares$10.2 Million0.0% of portfolio
About Erasca, Inc.
- Ticker ERAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 122,147,000
- Market Cap $288M
- Description
- Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; ...